首页> 外文期刊>Frontiers in Pharmacology >The Role of Ferroptosis in Cancer Development and Treatment Response
【24h】

The Role of Ferroptosis in Cancer Development and Treatment Response

机译:肥大症在癌症发展和治疗反应中的作用

获取原文
           

摘要

Ferroptosis is a process driven by accumulated iron-dependent lipid ROS that leads to cell death, which is a distinct regulated cell death comparing to other cell death. The lethal metabolic imbalance resulted from GSH depletion or inactivation of glutathione peroxidase 4 is the executor of ferroptosis within the cancer cell. Small molecules-induced ferroptosis has a strong inhibition of tumor growth and enhances the sensitivity of chemotherapeutic drugs, especially in the condition of drug resistance. These evidences have highlighted the importance of ferroptosis in cancer therapeutics, but the roles of ferroptosis in tumorigenesis and development remain unclear. This article provides an overview of the mechanisms of ferroptosis, highlights the role of ferroptosis in cancer and discusses strategies for therapeutic modulation.
机译:Ferroptosis是由累积的铁依赖性脂质ROS驱动的过程,该过程导致细胞死亡,与其他细胞死亡相比,它是受调控的细胞死亡。由谷胱甘肽耗竭或谷胱甘肽过氧化物酶4失活导致的致命代谢失衡是癌细胞内肥大化的执行者。小分子诱导的肥大病具有对肿瘤生长的强烈抑制作用,并增强了化疗药物的敏感性,尤其是在耐药性的情况下。这些证据凸显了肥大症在癌症治疗中的重要性,但是肥大症在肿瘤发生和发展中的作用仍不清楚。本文概述了肥大症的发病机制,强调了肥大症在癌症中的作用,并讨论了治疗性调节的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号